Accelerating Access to Life-Saving Cell Therapies
Industry:
Biopharma, Cell and Gene Therapy
Type:
Video
For patients battling critical conditions, time is everything. Yet, manufacturing bottlenecks continue to delay life-saving cell therapies—leaving up to 20% of eligible patients unable to receive treatment in time.
In this IBTV Spotlight from Advanced Therapies Week 2025, Georgi Makin (Head of Digital, IB Communications) hosts a crucial conversation with Sean Bartholomew (Biopharma Applications Engineer, Germfree), Edwin Stone (CEO, Cellular Origins), and Shannon Eaker (CTO, Xcell Biosciences) on how the industry can overcome these barriers and accelerate access to advanced therapies.
The discussion dives into:
- The biggest obstacles slowing down the delivery of cell therapies
- Innovations in rapid manufacturing and deployment
- Strategies to streamline processes and expand patient access
With the demand for cell therapies growing, the need for faster, more efficient delivery solutions has never been more pressing. This conversation sheds light on practical steps to break the bottleneck and ensure that patients receive the treatments they need—before it’s too late.
Watch now to learn how industry leaders are working to transform cell therapy accessibility.
You might also be interested in
Inside Germfree’s Isolator Engineering Process
Why Mobile and Modular Cleanrooms are Changing the Game in Bio-Manufacturing
Smarthood™: Setting a New Standard in IV Compounding
Contact us: Let's unlock your scientific potential together
Complete our contact form and a member of our commercial team will contact you within 24 hours.